Sprott’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sprott's BMY Position: Q3 2026 in Review
Sprott held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 8,515 shares worth $531K. The position accounts for 0.02% of the portfolio, ranked #177.
Sprott first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Sprott held 8,515 shares of Bristol-Myers Squibb worth $531K as of Q3 2026.
- Sprott left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.02% of Sprott's portfolio in Q3 2026, its #177 holding.
- Sprott first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.